These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26521983)

  • 41. Glutamine in the pathogenesis of acute hepatic encephalopathy.
    Rama Rao KV; Jayakumar AR; Norenberg MD
    Neurochem Int; 2012 Sep; 61(4):575-80. PubMed ID: 22285152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.
    Mondal P; Trigun SK
    Metab Brain Dis; 2014 Dec; 29(4):1007-15. PubMed ID: 24807590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of manganese intake improves neuropsychological manifestations in rats with minimal hepatic encephalopathy.
    Li Y; Mei LH; Qiang JW; Ji CX; Ju S
    Neuroscience; 2017 Apr; 347():148-155. PubMed ID: 28193543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
    Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.
    Thomas JW; Banner C; Whitman J; Mullen KD; Freese E
    Metab Brain Dis; 1988 Jun; 3(2):81-90. PubMed ID: 2903433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Precipitants of hepatic encephalopathy induce rapid astrocyte swelling in an oxidative stress dependent manner.
    Lachmann V; Görg B; Bidmon HJ; Keitel V; Häussinger D
    Arch Biochem Biophys; 2013 Aug; 536(2):143-51. PubMed ID: 23707757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy.
    Bosoi CR; Rose CF
    Metab Brain Dis; 2013 Jun; 28(2):175-8. PubMed ID: 23124921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls.
    Goldbecker A; Buchert R; Berding G; Bokemeyer M; Lichtinghagen R; Wilke F; Ahl B; Weissenborn K
    J Cereb Blood Flow Metab; 2010 Jul; 30(7):1384-93. PubMed ID: 20216550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.
    Holecek M
    Nutrition; 2013 Oct; 29(10):1186-91. PubMed ID: 23756281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited.
    Mpabanzi L; Olde Damink SW; van de Poll MC; Soeters PB; Jalan R; Dejong CH
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):449-54. PubMed ID: 21537121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical science workshop: targeting the gut-liver-brain axis.
    Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
    Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.
    Higashi T
    Gastroenterol Jpn; 1982 Apr; 17(2):125-34. PubMed ID: 7106499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ammonia: key factor in the pathogenesis of hepatic encephalopathy.
    Butterworth RF; Giguère JF; Michaud J; Lavoie J; Layrargues GP
    Neurochem Pathol; 1987; 6(1-2):1-12. PubMed ID: 3306479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatic encephalopathy. The Danish Society of Hepatology].
    Sørensen M; Vilstrup H; Keiding S; Ott P;
    Ugeskr Laeger; 2007 Mar; 169(12):1106. PubMed ID: 17394817
    [No Abstract]   [Full Text] [Related]  

  • 56. Inflammation and hepatic encephalopathy.
    Coltart I; Tranah TH; Shawcross DL
    Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic encephalopathy in alcoholic cirrhosis.
    Butterworth RF
    Handb Clin Neurol; 2014; 125():589-602. PubMed ID: 25307598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy.
    Häussinger D; Görg B; Reinehr R; Schliess F
    Metab Brain Dis; 2005 Dec; 20(4):285-94. PubMed ID: 16382339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.
    Yoshida Y; Higashi T; Nouso K; Nakatsukasa H; Nakamura SI; Watanabe A; Tsuji T
    Acta Med Okayama; 2001 Dec; 55(6):349-55. PubMed ID: 11779097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy.
    Leke R; Bak LK; Iversen P; Sørensen M; Keiding S; Vilstrup H; Ott P; Portela LV; Schousboe A; Waagepetersen HS
    J Neurochem; 2011 Jun; 117(5):824-32. PubMed ID: 21395584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.